Many credit cards offer balance transfers with no fees but come with drawbacks like shorter 0% APR periods or strict membership rules. Paying a small balance transfer fee, typically 3% to 5%, often unlocks longer 0% intro APR periods, saving more on interest overall. The Citi® Diamond Preferred® Card, for example, charges a 3% fee for transfers within four months but offers 21 months of 0% APR on balance transfers, making it a top choice for reducing debt cost-effectively. Investors should prioritize cards with the longest 0% APR offers and manageable fees to maximize savings and pay down debt faster.
This story on 0% intro APR credit cards with no balance transfer fees is presented with market context from Pluang's Financials sector data. For readers following Financials, here is Pluang's market snapshot as of Sep 25, 2026 18:13 WIB: Out of 85 priced US Financials stocks, 63 rose and 15 fell today. Notable movers include AVAT at USD 1.95 with a 1-day change of +8.03% and a typical hold time of 10 days, RJF at USD 165.19 up 4.05% with a typical hold time of 73 days, and NMR at USD 10.16 up 3.99% with 100% buy order activity and a typical hold time of 54 days.
Assured Guaranty Ltd. (NYSE: AGO) saw its stock price pressured to a new 52-week low of $68.04 despite a recent upgrade to "Buy" by Roth Capital. The company is involved in the financial restructuring of Brightline Florida, where a subsidiary insured...
Legacy Education Inc. reported Q4 2026 earnings with an EPS of $0.13, missing analyst estimates of $0.15, and revenue of $20.1 million, slightly below expectations. Despite this, the company achieved a 12% year-over-year revenue increase in Q4 and a ...
Carnival Corporation & plc is set to report Q3 earnings with analysts forecasting $8.39 billion in revenue and $1.36 EPS, reflecting a 4.9% decline from last year. The company's stock has dropped 27% recently due to a 30% surge in Brent oil prices, w...
Oklo, a pre-revenue nuclear tech company, is developing advanced small modular reactors (SMRs) called Aurora Powerhouses aimed at clean energy for data centers. UBS set a price target of $41, indicating a 7.08% upside from the current $38.29 stock pr...
AbbVie and Johnson & Johnson are both strong dividend stocks trading near their 52-week highs, but they differ significantly in risk and growth. AbbVie shows faster revenue growth and a higher dividend yield, driven by its immunology drugs, but faces...
